Nicole D Williamson, MS, CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 5406 Merle Hay Rd, Johnston, IA 50131 Phone: 515-727-8750 Fax: 515-727-8757 |
Nicole Scharn Speech-Language Pathologist Medicare: Medicare Enrolled Practice Location: 5555 Pioneer Pkwy, Johnston, IA 50131 Phone: 515-534-0300 |
Megan Roome, MSP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 5406 Merle Hay Rd, Johnston, IA 50131 Phone: 515-727-8750 Fax: 515-727-8757 |
Samantha Nicole Walker, MA, CF-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 5530 West Pkwy Ste 300, Johnston, IA 50131 Phone: 515-419-4270 |
Jerica Stitz, SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 5406 Merle Hay Rd, Johnston, IA 50131 Phone: 515-727-8750 Fax: 515-727-8757 |
Megan Elizabeth Tucker, SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 5406 Merle Hay Rd, Johnston, IA 50131 Phone: 515-727-8750 Fax: 515-727-8757 |
Abbigayle Ruthann Kay Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 5406 Merle Hay Rd, Johnston, IA 50131 Phone: 515-727-8750 Fax: 515-727-8757 |
Julie Glenn Palmer, CFY-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 5406 Merle Hay Rd, Johnston, IA 50131 Phone: 515-727-0750 |
Kelli Sellnow Snyder, SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 5406 Merle Hay Rd, Johnston, IA 50131 Phone: 515-727-8750 Fax: 515-727-8757 |
Lindsey Marie Hundson, MA, CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 5406 Merle Hay Rd, Johnston, IA 50131 Phone: 515-727-8750 Fax: 515-727-8757 |
Abigail Stromley Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 5406 Merle Hay Rd, Johnston, IA 50131 Phone: 515-727-8750 |
Emily Wilson Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 5530 West Pkwy Ste 300, Johnston, IA 50131 Phone: 515-419-4270 |
Kaitlyn Van Ee Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 5406 Merle Hay Rd, Johnston, IA 50131 Phone: 515-727-8750 Fax: 515-727-8757 |
Ms. Katherine Lee Clark, M.A. Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 5406 Merle Hay Rd, Johnston, IA 50131 Phone: 515-727-8750 Fax: 515-727-8557 |
Mrs. Leora Mae Scherz, MS, CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 5406 Merle Hay Rd, Johnston, IA 50131 Phone: 515-727-8757 |
Megan Beth Dean, M.A., CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 5406 Merle Hay Rd., Childserve Therapy, Inc., Johnston, IA 50131 Phone: 515-727-8750 Fax: 515-727-8757 |
Mckinley Schubert Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 5406 Merle Hay Rd, Johnston, IA 50131 Phone: 515-727-8750 |
Jillian Day Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 6901 Peckham St, Johnston, IA 50131 Phone: 515-393-7997 |
Chloe Rains, M.S., CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 5406 Merle Hay Rd, Johnston, IA 50131 Phone: 515-727-8750 Fax: 515-727-8757 |
Sarah Dotson, M.S., CF-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 5406 Merle Hay Rd, Johnston, IA 50131 Phone: 515-727-8750 |
News Archive
Oligomerix, Inc., a privately held company pioneering the development of tau oligomer inhibitors for Alzheimer's disease and related neurodegenerative disorders, and the Feinstein Institutes for Medical Research announced today the publication of preclinical data demonstrating that an oral small molecule drug inhibits the formation of neurotoxic tau oligomers in an animal model of tau aggregation most relevant to AD.
Scientists at the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health, have demonstrated why certain immune cells chronically exposed to HIV shut down, and how they can be reactivated.
Theraclone Sciences, Inc., a therapeutic antibody discovery and development company, announced today that they have entered into a multi-year research and development collaboration with Pfizer. The collaboration will use Theraclone's I-STARâ„¢ technology to discover broadly protective monoclonal antibodies against up to four undisclosed targets in the areas of infectious disease and cancer.
Stenting is safe and effective and superior to balloon angioplasty for treatment of venous stenosis in patients with deep vein thrombosis, according to results from EVISTA-DVT, presented today as a Late-Breaking Clinical Trial at the Society for Cardiovascular Angiography and Interventions 2011 Scientific Sessions in Baltimore.
Aestus Therapeutics, Inc. announced that it has been awarded a $2 million Small Business Innovative Research (SBIR) grant from the National Institutes of Health (NIH). The grant, from the NIH's National Institute of Neurological Disorders and Stroke (NINDS), will fund clinical trials of Aestus's novel, first-in-class treatment for chronic neuropathic pain.
› Verified 1 days ago